Yüklüyor......

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

BACKGROUND: Pre-treatment factors that increase smokers’ risk of experiencing neuropsychiatric adverse events (NPSAEs) when quitting smoking are unknown. OBJECTIVE: To identify baseline smoker characteristics beyond the history of mental illness that predict which participants were more likely to ex...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Gen Intern Med
Asıl Yazarlar: Anthenelli, Robert M., Gaffney, Michael, Benowitz, Neal L., West, Robert, McRae, Thomas, Russ, Cristina, Lawrence, David, St. Aubin, Lisa, Krishen, Alok, Evins, A. Eden
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544691/
https://ncbi.nlm.nih.gov/pubmed/30847828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-019-04858-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!